Sort
16,300 grants matching “fatty liver disease”
Sleep Apnea and Dysregulation of Lipid Metabolism
$349,879Vsevolod Y Polotsky · Johns Hopkins University · R01 · FY2008 · HL
Molecular mechanisms of post-transplant recurrent alcoholic liver disease
$349,875Rotonya M Carr · University Of Washington · R01 · FY2025 · AA
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2021 · ES
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2022 · ES
Endocrine disruptor mediated activation of PXR causes dyslipidemia and atherosclerosis
$349,875Changcheng Zhou · University Of California Riverside · R01 · FY2020 · ES
Molecular mechanisms of post-transplant recurrent alcoholic liver disease
$349,875Rotonya M Carr · University Of Washington · R01 · FY2023 · AA
Molecular mechanisms of post-transplant recurrent alcoholic liver disease
$349,875Rotonya M Carr · University Of Washington · R01 · FY2024 · AA
Fatty Liver Preventive Effects and High Dose Hepatotoxicity of Tea Polyphenols
$349,874Joshua D Lambert · Pennsylvania State University, The · R01 · FY2011 · AT
Pathobiology of Nonalcoholic Steatohepatitis
$349,800Petra Hirsova · Mayo Clinic Rochester · R01 · FY2021 · DK
Pathobiology of Nonalcoholic Steatohepatitis
$349,800Petra Hirsova · Mayo Clinic Rochester · R01 · FY2023 · DK
Pathobiology of Nonalcoholic Steatohepatitis
$349,800Petra Hirsova · Mayo Clinic Rochester · R01 · FY2022 · DK
Pathobiology of Nonalcoholic Steatohepatitis
$349,800Petra Hirsova · Mayo Clinic Rochester · R01 · FY2025 · DK
Study of alcoholic ketoacidosis in mice
$349,770Inyeong Choi · Emory University · R01 · FY2025 · AA
Expression of the type 3 InsP3 receptor in the injured hepatocyte: mechanisms and effects
$349,685Michael H Nathanson · Yale University · P01 · FY2016 · DK
Significance of Angiotensinogen Variants in Hypertension
$349,641Curt Daniel Sigmund · University Of Iowa · R01 · FY2008 · HL
Significance of Angiotensinogen Variants in Hypertension
$349,641Curt Daniel Sigmund · University Of Iowa · R01 · FY2007 · HL
Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN)
$349,622Norah A. Terrault · University Of California, San Francisco · U01 · FY2017 · DK
GENOMIC ANALYSIS OF THE SRC FAMILY OF COREGULATORS IN TISSUE METABOLISM
$349,560Francesco John Demayo · Baylor College Of Medicine · P01 · FY2007 · DK
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
$349,544Sonia Caprio · Yale University · R01 · FY2013 · HD
Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy
$349,439Lonnie D Shea · Northwestern University · R01 · FY2012 · EB
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
$349,309Dale B Hales · Southern Illinois University Carbondale · R01 · FY2015 · AT
Therapeutic Efficacy of Flaxseed in the Treatment of Ovarian Cancer
$349,309Dale B Hales · Southern Illinois University Carbondale · R01 · FY2014 · AT
Leptin and peripheral glucose metabolism
$349,272Ruth B Harris · Augusta University · R01 · FY2010 · DK
USE OF DYRK1A/B KINASE INHIBITORS FOR THE TREATMENT OF LIVER DISEASES
$349,235Gian Luca Araldi · Avanti Biosciences, Inc. · R43 · FY2023 · DK
Role of Carboxylesterase1 in PPARgamma, RAR and RXR Signaling in Macrophages
$349,200Abdolsamad Borazjani · Mississippi State University · R15 · FY2015 · GM